FA
NVO

Forefront Analytics’s Novo Nordisk NVO Stock Holding History

Forefront Analytics’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-42
Closed -$1.26K – 114
2020
Q1 		$1.26K Buy
+42
New +$1.25K ﹤0.01% 121

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Forefront Analytics's NVO Position: Q2 2020 in Review

Forefront Analytics sold out of Novo Nordisk (NVO) in Q2 2020, closing a stake of 42 shares — an estimated $1.26K sold.

Forefront Analytics first reported a position in NVO in Q1 2020 and held it in 1 quarter. The position peaked at $1.26K in Q1 2020. 660 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

  • Forefront Analytics reported no remaining Novo Nordisk position as of Q2 2020 after selling out during the quarter.
  • Forefront Analytics sold 42 Novo Nordisk shares in Q2 2020, an estimated $1.26K.
  • Forefront Analytics first reported a position in Novo Nordisk in Q1 2020 and held it in 1 quarter.
  • Forefront Analytics's Novo Nordisk position peaked at $1.26K in Q1 2020.
  • 660 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Forefront Analytics's 13F filing for Q2 2020, filed 10 Aug 2020.